Find a trial

Our clinical trials database will help you look for a clinical trial that might be suitable for you. We hope this helps you to make informed decisions and choices about your lymphoma treatment and care.

Questions about Lymphoma TrialsLink and how to use it? Read more about Lymphoma TrialsLink here or if you have a general question about clinical trials in the UK or Lymphoma TrialsLink, please contact us at trialslink@lymphoma-action.org.uk.

Note: We are not able to refer people to specific trials. If you’re interested in taking part in a trial you have found on Lymphoma TrialsLink, we recommend that you print the trial summary and discuss it with your consultant. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.

Trial name	Closing date Sort ascending
Bellwave-011: A phase 3 trial of nemabrutinib in people with chronic lymphocytic leukaemia or small lymphocytic lymphoma	30 Sep 2032
ZUMA-23: A phase 3 trial of axicabtagene ciloleucel in people with high-risk large B-cell lymphoma	1 Mar 2031
TrAVeRse: A phase 2 trial of acalabrutinib, venetoclax and rituximab in patients with untreated mantle cell lymphoma	1 Nov 2029
Mahogany: A phase 3 trial of zanubrutinib and anti-CD20 in people with relapsed or refractory follicular or marginal zone lymphoma	1 Jun 2029
GO44145: A phase 3 trial of glofitamab and Pola-R-CHP in people with B-cell lymphoma	28 Feb 2029
BGB-11417: A phase 2 trial of BGB-11417 in people with relapsed or refractory Waldenstrom’s Macroglobulinaemia	1 Sep 2028
ALETA-001: A phase 1 and 2 trial of ALETA-001 in patients with relapsed or refractory non-Hodgkin lymphoma	1 Dec 2027
MX-1026: A phase 2 trial of nemabrutinib (MK-1026) in people with certain types of relapsed or refractory non-Hodgkin lymphoma	19 Mar 2027
GLOBRYTE: A phase 3 trial of glofitamab in people with relapsed or refractory mantle cell lymphoma	31 Dec 2026
EPCORE DLBCL-3: A phase 3 trial of epcoritamab with or without lenalidomide in patients with diffuse large B-cell lymphoma	1 Apr 2026
KB-0742: A phase 1 and 2 trial of KB-0742 in people with relapsed or refractory non-Hodgkin lymphoma	1 Dec 2025